Michèle Rasamoelisolo

Mining biomarkers in human sera using proteomic tools

Rulin Zhang, Lisa Barker, Deborah Pinchev et al. · PROTEOMICS · 2004 · 186 citations

Low Abundance Proteins, Protein Purification, Proteomic Technology +23

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

Orit Cohen‐Barak, Sivan Weiss, Michèle Rasamoelisolo et al. · Cephalalgia · 2018 · 54 citations

Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine

Jill Fiedler‐Kelly, Orit Cohen‐Barak, Denise Morris et al. · British Journal of Clinical Pharmacology · 2019 · 26 citations · Full text

A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck

Glen C. MacDonald, Michèle Rasamoelisolo, J. Entwistle et al. · Medical Oncology · 2008 · 24 citations

Oncology, Squamous Cell Carcinoma, Medicine +7

Fine Characterization of a Series of New Monoclonal Antibodies Directed against Glycophorin A

Michèle Rasamoelisolo, Marcin Czerwiński, Vincent Bruneau et al. · Vox Sanguinis · 1997 · 23 citations